EFHC2
EF-hand domain-containing family member C2
Also known as: EFHC2_HUMAN, FLJ22843, MRX74
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5JST6
- Gene
- EFHC2
- Ensembl
- ENSG00000183690
- Chromosome
- X
- Canonical length
- 749 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a protein which contains three DM10 domains and three calcium-binding EF-hand motifs. A related protein is encoded by a gene on chromosome 6. It has been suggested that both proteins are involved in the development of epilepsy (PMID: 15258581, 16112844) and that this gene may be associated with fear recognition in individuals with Turner syndrome. [provided by RefSeq, Aug 2011]
Canonical amino-acid sequenceUniProt
749 residues, UniProt reviewed canonical sequence.
>Q5JST6|EFHC2
1 MALPLLPGNS FNRNVGKEKF HKSQHWGFCN NVMMLVSDEK PGIGGEPLLG QKIKPKCSIY
61 PKGDGSDVPS WVAFDKQVLS FDAYLEEEVL DKSQTNYRIR YYKIYFYPED DTIQVNEPEV
121 KNSGLLQGTS IRRHRITLPP PDEDQFYTVY HFNVGTEVVF YGRTFKIYDC DAFTRNFLRK
181 IGVKVNPPVQ CPEDPYMKIR REVVEHVEPL RPYESLDTLK QFLQYHGKIL CFFCLWDDSV
241 SMFGDRRELI LHYFLCDDTI EIKELLPHSS GRDALKMFLR RSKLPKNCPP RVYQPGQITD
301 RAVLNSYGDF IKNQADGYLF DRYKLGKVDQ EFYKDSDLSL GVTINVWGRK VLLYDCDEFT
361 KSYYKSKYGI ENFTSVSCKP PSPPPKIERK FPPYNGFGSE EDSLRNCIDL KPTPHRRNFK
421 KFMEKDSYGS KSNILRFFAK LVTDKCVDLD RMFVISYYLG DDTISVFEPI ERNSGIAGGM
481 FLKRSRVKKP GQEVFKSELS EYIKAEELYI GVTVNVNGYL FRLLNADEYT LNYMEQNTDK
541 YPFSNLKLAL QKLKQEEGKS RELKQVFKAA DSKHTNMVDY NTFRDILMSL TVGNLAEQEF
601 VTIARHYRVP EGTCSDMDFL IALAHEKFKK NMFENFDTFI YSCVYEDREK KNVLPTKDIK
661 RLCKSSRLPL SDDLLESLLS RFEDSEKQID YKSFFSALNW RKNPVPELQP ASYLKERCED
721 VWLGMPSPIP AKYIDYWTFL KDAFGLEEELocalizationUniProt · AlphaFold · HPA
Whether an antibody against EFHC2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 26 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 26 nTPM
- fallopian tube: 14 nTPM
- salivary gland: 7.7 nTPM
- testis: 6.3 nTPM
- endometrium: 3.4 nTPM
- seminal vesicle: 3.4 nTPM
Single-cell type
- choroid plexus epithelial cells: 393 nCPM
- ependymal cells: 361 nCPM
- respiratory ciliated cells: 297 nCPM
- fallopian tube ciliated cells: 237 nCPM
- endometrial ciliated cells: 187 nCPM
- epididymal efferent duct ciliated cells: 147 nCPM
Immune cell
- basophil: 16 nTPM
- NK-cell: 5.8 nTPM
- gdT-cell: 1.5 nTPM
- neutrophil: 1.5 nTPM
- total PBMC: 0.9 nTPM
- naive CD8 T-cell: 0.7 nTPM
Brain region
- choroid plexus: 37 nTPM
- medulla oblongata: 12 nTPM
- midbrain: 8.9 nTPM
- spinal cord: 6.2 nTPM
- thalamus: 5.9 nTPM
- white matter: 5.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.15
- gnomAD pLI
- 1
- gnomAD missense Z
- 0.62
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to leukemia inhibitory factor
- flagellated sperm motility
- regulation of neuron projection development
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EFHC2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EFHC2 as an antibody target. Whether an autoantibody or antibody against EFHC2 could matter depends on whether native EFHC2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EFHC2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EFHC2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...